3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid
|
|
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid 속성
- 녹는점
- >172°C (dec.)
- 저장 조건
- -20°C Freezer, Under inert atmosphere
- 용해도
- DMSO(약간 용해됨), 메탄올(약간 용해됨)
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 색상
- 흰색에서 황백색까지
안전
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid C화학적 특성, 용도, 생산
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid 준비 용품 및 원자재
원자재
준비 용품
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid 공급 업체
글로벌( 10)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-83725681-603 |
China | 4505 | 50 | |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-52878169 15701683040 |
sales@bjcomparison.com | China | 4744 | 58 |
Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 15185 | 58 |
Anhui Feixiang Pharmaceutical Technology Co., Ltd. | 13349001619 |
sales@feixiangpharm.com | China | 1008 | 58 |
Shenzhen Botel Biotechnology Co. Ltd. | 0755-22202135 13316968096 |
1979313431@qq.com | China | 8285 | 58 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 |
shiqingran@wzxchem.com | China | 3592 | 58 |
Shenzhen Hengfeng Wanda Pharmaceutical Technology Co., Ltd | 0755-22677922 18126518403 |
2851922760@qq.com | China | 5043 | 58 |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 14092 | 58 |
Shenzhen Excellent Biomedical Technology Co., Ltd. | 18318671572 |
2850803126@qq.com | China | 4993 | 58 |
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid 관련 검색:
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI)
(3S,4S)-Tofacitinib
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)-
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE
Tofacitinib Impurity 6
Butyl 3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanoate